5-Fluorouracil (5-FU) Continuous Intravenous Infusion Compared with Bolus Administration. Final Results of a Randomised Trial in Metastatic Colorectal Cancer

Author： Rougier P.   Paillot B.   LaPlanche A.   Morvan F.   Seitz J.F.   Rekacewicz C.   Laplaige P.   Jacob J.   Grandjouan S.   Tigaud J.M.   Fabri M.C.   Luboinski M.   Ducreux M.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.33, Iss.11, 1997-10, pp. : 1789-1793

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Plasma and Salivary Pharmacokinetics of 5-Fluorouracil (5-FU) in Patients with Metastatic Colorectal Cancer Receiving 5-FU Bolus Plus Continuous Infusion with High-dose Folinic Acid

By Joulia J.M.   Pinguet F.   Ychou M.   Duffour J.   Astre C.   Bressolle F.  

European Journal of Cancer, Vol. 35, Iss. 2, 1999-02 ,pp. : 296-301

Elsevier

Access to resources Recommend Favorite

Final Results of a Phase III Clinical Trial on Adjuvant Intraportal Infusion with Heparin and 5-Fluorouracil (5-FU) in Resectable Colon Cancer (EORTC GITCCG 1983-1987)

By Nitti D.   Wils J.   Sahmoud T.   Curran D.   Couvreur M.L.   Lise M.   Rauschecker H.   Guimaraes dos Santos J.   Stremmel W.   Roelofsen F.  

European Journal of Cancer, Vol. 33, Iss. 8, 1997-07 ,pp. : 1209-1215

Elsevier

Access to resources Recommend Favorite

Bolus injection (2-4min) versus short-term (10-20min) infusion of 5-fluorouracil in patients with advanced colorectal cancer: a prospective randomised trial

By Glimelius B.   Jakobsen A.   Graf W.   Berglund A.   Gadeberg C.   Hansen P.   Kjaer M.   Brunsgaard N.   Sandberg E.   Lindberg B.   Sellstrom H.   Lorentz T.   Pahlman L.   Gustavsson B.  

European Journal of Cancer, Vol. 34, Iss. 5, 1998-04 ,pp. : 674-678

Elsevier

Access to resources Recommend Favorite

CPT-11 (Irinotecan) addition to bimonthly, high-dose leucovorin and bolus and continuous-infusion 5-fluorouracil (FOLFIRI) for pretreated metastatic colorectal cancer

By Andre T.   Louvet C.   Maindrault-Goebel F.   Couteau C.   Mabro M.   Lotz J.P.   Gilles-Amar V.   Krulik M.   Carola E.   Izrael V.   de Gramont A.  

European Journal of Cancer, Vol. 35, Iss. 9, 1999-09 ,pp. : 1343-1347

Elsevier

Access to resources Recommend Favorite

A Phase I Trial of 5-day Chronomodulated Infusion of 5-Fluorouracil and 1-Folinic Acid in Patients with Metastatic Colorectal Cancer

By Garufi C.   Levi F.   Aschelter A.M.   Pace R.   Giunta S.   Nistico C.   Galla D.A.P.   Silecchia G.F.   Franchi F.   Narduzzi C.   Terzoli E.  

European Journal of Cancer, Vol. 33, Iss. 10, 1997-09 ,pp. : 1566-1571

Elsevier

Access to resources Recommend Favorite